AlphaYouHC
Insider selling
Hunter C Smith sold $6.6M of Rhythm Pharmaceuticals, Inc. (RYTM) stock
Hunter C Smith, Chief Financial Officer of Rhythm Pharmaceuticals, Inc. (RYTM), sold 62,774 shares of RYTM stock worth $6.6M, per an SEC Form 4 filed Sep 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 31, 2026, 1 day before it was made public.
RYTM has moved -6.9% since the trade date, from $106.13 to $98.83 (Sep 21, 2026 close).
- Traded
- Aug 31, 2026
- Disclosed
- Sep 1, 2026
- Filing delay
- 1 day
- Price since
- -6.9%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More RYTM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.